ロード中...
Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis
C3 glomerulopathy (C3G) is characterized by C3 deposits with minimal immunoglobulin deposition caused by alternative complement pathway dysregulation. Unfortunately, no therapeutic intervention has consistently improved outcomes for patients with C3G. Eculizumab, a monoclonal antibody to C5, is curr...
保存先:
| 出版年: | Clin Kidney J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515899/ https://ncbi.nlm.nih.gov/pubmed/26251714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv044 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|